Hiroshi Yagata
Overview
Explore the profile of Hiroshi Yagata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
446
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sato I, Yagata H, Ohashi Y
Biol Pharm Bull
. 2015 Mar;
38(1):53-7.
PMID: 25744458
In use of a claims database for a study, an inaccurate diagnosis of breast cancer based on claims data may lead to invalid study results. The aim of this study...
12.
Yamauchi H, Nakagawa C, Yamashige S, Takei H, Yagata H, Yoshida A, et al.
BMC Health Serv Res
. 2014 Sep;
14:372.
PMID: 25190451
Background: Breast-cancer incidence and mortality have been increasing in Japan. Japanese-specific clinical validity and utility data for the 21-gene assay (Oncotype DX® Breast Cancer Assay; Genomic Health, Inc., Redwood City,...
13.
Matsuda N, Hayashi N, Ohde S, Yagata H, Kajiura Y, Yoshida A, et al.
J Surg Oncol
. 2014 Mar;
109(8):764-9.
PMID: 24647874
Background: We sought to develop and validate a predictive model of locoregional recurrence (LRR) in patients who underwent breast-conserving therapy (BCT) after neoadjuvant chemotherapy (NAC). Patients And Methods: The clinicopathological...
14.
Yamauchi H, Nakagawa C, Takei H, Chao C, Yoshizawa C, Yagata H, et al.
Clin Breast Cancer
. 2013 Dec;
14(3):191-7.
PMID: 24321102
Background: In this study we investigated if the 21-gene assay result affects adjuvant decision-making in Japanese women with ER+ invasive EBC. Patients And Methods: A total of 124 consecutive eligible...
15.
Yagata H, Yamauchi H, Tsugawa K, Hayashi N, Yoshida A, Kajiura Y, et al.
Clin Breast Cancer
. 2013 Nov;
13(6):471-7.
PMID: 24267732
Introduction: Several studies have assessed the feasibility of sentinel lymph node biopsy (SLNB) after NAC in patients with breast cancer, but diagnostic accuracy has varied. We prospectively evaluated the diagnostic...
16.
Onoda T, Yamauchi H, Yagata H, Tsugawa K, Hayashi N, Yoshida A, et al.
Breast Cancer
. 2013 Oct;
22(4):406-12.
PMID: 24081457
Background: OncotypeDX(®) (ODX) is a well-validated assay for breast cancer treatment planning. We explored whether the conventional pathological factors could pick up high risk patients without the help of the...
17.
Takamoto Y, Tsunoda H, Kikuchi M, Hayashi N, Honda S, Koyama T, et al.
Asian Pac J Cancer Prev
. 2013 Jun;
14(5):3037-40.
PMID: 23803075
Introduction: Mammography is the most basic modality in breast cancer imaging. However, the overlap of breast tissue depicted on conventional two-dimensional mammography (2DMMG) may create significant obstacles to detecting abnormalities,...
18.
Yagata H, Takahashi M
Nihon Rinsho
. 2013 Jan;
70 Suppl 7:731-5.
PMID: 23350495
No abstract available.
19.
Yoshida A, Hayashi N, Akiyama F, Yamauchi H, Uruno T, Kikuchi M, et al.
Clin Breast Cancer
. 2012 Oct;
12(6):398-403.
PMID: 23083502
Background: The radiologic and pathologic characteristics of ductal carcinoma in situ (DCIS) that involves sclerosing adenosis (SA) (SA DCIS) resemble those of invasive carcinoma. However, differences in the clinical features...
20.
Neuroendocrine cells associated with neuroendocrine carcinoma of the breast: nature and significance
Kawasaki T, Mochizuki K, Yamauchi H, Inoue S, Kondo T, Oishi N, et al.
J Clin Pathol
. 2012 May;
65(8):699-703.
PMID: 22554967
Background: The developmental mechanisms of breast neuroendocrine carcinoma (B-NEC) have not been sufficiently analysed and are not well understood. Aims: To investigate NE cells in the background tissues surrounding B-NECs....